What to Expect From Johnson & Johnson’s Q3 2025 Earnings Report

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a healthcare company recognized for its leadership in pharmaceuticals, medical technologies, and consumer health products. Valued at a market cap of $428 billion, the company focuses on improving human health and well-being through scientific innovation, patient-centered care, and a commitment to addressing some of the world’s most pressing health challenges. The company is expected to announce its fiscal Q3 earnings for 2025 before the market open ...